A study from Michigan Medicine using 2020-2023 data found a significant increase in the use of weight loss drugs like Wegovy and Ozempic among adolescents and young adults in the U.S., particularly among females. Concerns include the rising off-label use of these drugs and their long-term impacts on youth.
Public interest in weight loss medications such as Wegovy and Ozempic is rapidly increasing, yet there is a surprising lack of national data on their dispensing patterns in the United States.shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.
GLP-1RAs were approved for type 2 diabetes in 2005 and for weight management in 2014. Interest in these drugs surged in 2021 when semaglutide was approved for weight management in adults under the brand name Wegovy, and increased even further when Wegovy was approved for weight management in adolescents at the end of 2022.
“This finding suggests increasing off-label use of Ozempic for weight management in adolescents and young adults,” said Kao-Ping Chua, MD, the senior author of the paper and a member of the CHEAR Center.
Technology Technology Latest News, Technology Technology Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: SciTechDaily1 - 🏆 84. / 68 Read more »